Citigroup’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-17,286
| Closed | -$2.36M | – | 7771 |
|
|
2020
Q3 | $2.36M | Sell |
17,286
-13,917
| -45% | -$1.48M | ﹤0.01% | 2504 |
|
|
2020
Q2 | $3.01M | Buy |
31,203
+5,381
| +21% | +$449K | ﹤0.01% | 2340 |
|
|
2020
Q1 | $1.21M | Buy |
25,822
+11,293
| +78% | +$724K | ﹤0.01% | 2973 |
|
|
2019
Q4 | $1.06M | Buy |
14,529
+4,575
| +46% | +$278K | ﹤0.01% | 3693 |
|
|
2019
Q3 | $519K | Sell |
9,954
-2,275
| -19% | -$121K | ﹤0.01% | 4307 |
|
|
2019
Q2 | $613K | Buy |
12,229
+2,314
| +23% | +$113K | ﹤0.01% | 4208 |
|
|
2019
Q1 | $516K | Buy |
9,915
+513
| +5% | +$23.6K | ﹤0.01% | 4149 |
|
|
2018
Q4 | $459K | Buy |
9,402
+5,157
| +121% | +$284K | ﹤0.01% | 4214 |
|
|
2018
Q3 | $277K | Buy |
4,245
+189
| +5% | +$11.1K | ﹤0.01% | 4916 |
|
|
2018
Q2 | $201K | Buy |
4,056
+3,534
| +677% | +$171K | ﹤0.01% | 5066 |
|
|
2018
Q1 | $26K | Sell |
522
-13,776
| -96% | -$716K | ﹤0.01% | 6611 |
|
|
2017
Q4 | $601K | Buy |
14,298
+13,562
| +1,843% | +$523K | ﹤0.01% | 3910 |
|
|
2017
Q3 | $32K | Sell |
736
-2,040
| -73% | -$65.1K | ﹤0.01% | 6224 |
|
|
2017
Q2 | $37K | Buy |
2,776
+2,748
| +9,814% | +$36.2K | ﹤0.01% | 5990 |
|
|
2017
Q1 | $0 | Sell |
28
-13,037
| -100% | -$167K | ﹤0.01% | 7414 |
|
|
2016
Q4 | $169K | Buy |
13,065
+12,141
| +1,314% | +$187K | ﹤0.01% | 5425 |
|
|
2016
Q3 | $15K | Sell |
924
-210
| -19% | -$3.79K | ﹤0.01% | 6367 |
|
|
2016
Q2 | $14K | Sell |
1,134
-3,970
| -78% | -$49.6K | ﹤0.01% | 6396 |
|
|
2016
Q1 | $54K | Buy |
5,104
+3,194
| +167% | +$29.1K | ﹤0.01% | 6081 |
|
|
2015
Q4 | $28K | Buy |
+1,910
| New | +$23.4K | ﹤0.01% | 6313 |
|
Citigroup's MYOK Position: Q4 2020 in Review
Citigroup sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 17,286 shares — an estimated $2.36M sold.
Citigroup first reported a position in MYOK in Q4 2015 and held it in 20 quarters. The position peaked at $3.01M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Citigroup reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Citigroup sold 17,286 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $2.36M.
- Citigroup first reported a position in MyoKardia, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Citigroup's MyoKardia, Inc. Common Stock position peaked at $3.01M in Q2 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.